Taysha Gene Therapies, Inc.

NASDAQ
TSHA
Stock
Yield per half year: +66.56%
Dividend yield: 0%
Sector: Healthcare

Reporting Taysha Gene Therapies, Inc.

Capitalization

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Капитализация, млрд $
0.3781 0.2828 0.0706 0.2754 0.1238 0.2517 -7.62
Выручка, млрд $
0.0025 0.0155 0.0083 0.0083 0.0088 49.18
Чистая прибыль, млрд $
-0.0011 -0.06 -0.175 -0.1696 -0.1116 -0.0893 -0.0893 -0.1211 8.28
EV, млрд $
0.2331 0.1484 0.0714 0.3097 0.3569 0.3569 0.2239 8.89
EBIT, млрд $
-0.0045 -0.043 -0.1733 -0.1622 -0.1066 -0.0892 -0.0892 -0.1149 15.71
EBITDA, млрд $
-0.0011 -0.06 -0.1416 -0.1597 -0.1052 -0.088 -0.088 -0.1109 7.96
OIBDA, млрд $
-0.043 -0.1706 -0.1526 -0.0661 -0.0901 -0.0901 -0.1045 15.94
Баланс стоимость, млрд $
-0.0011 -0.0611 -0.2356 0.000949 0.0749 0.0715 0.0715 -0.0299 -203.19
FCF, млрд $
0.000135 -0.04 -0.139 -0.1133 -0.0804 -0.0816 -0.0816 -0.0909 15.33
Операционный денежный поток, млрд $
-0.0307 -0.0307 -0.117 -0.0884 -0.073 -0.0812 -0.0812 -0.0781 21.47
Операционная прибыль, млрд $
-0.0011 -0.043 -0.173 -0.1624 -0.0724 -0.0915 -0.0915 -0.1085 16.30
Операционные расходы, млрд $
0.0011 0.043 0.1733 0.1285 0.0879 0.0998 0.0998 0.1065 18.34
CAPEX, млрд $
0.0001 0.009 0.022 0.0249 0.0074 0.000374 0.000374 0.0127 -47.07


Balance sheet

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Наличность, млрд $
0.2513 0.1888 0.0879 0.1439 0.139 0.139 0.1622 -11.17
Total Current Assets $
0.0000 0.2513 0.1596 0.0964 0.1499 0.1421 0.1421 0.1599 -10.78
Чистые активы, млрд $
-0.000135 0.2513 0.0954 0.0507 -0.0149 0.0964 0.0765 156.19
Активы, млрд $
0.0000 0.2589 0.214 0.1263 0.1727 0.1604 0.1604 0.1865 -9.13
Short Term Debt $
0.0015 0.0016 0.0019 0.0019 0.0017 8.20
Long Term Debt $
0.0372 0.038 0.0405 0.0439 0.0439 0.0399 4.23
Задолженность, млрд $
0.00015 0.0076 0.1186 0.1253 0.0978 0.0888 0.0888 0.0876 63.50
Чистый долг, млрд $
-0.2513 -0.1491 -0.028 -0.0828 -0.0759 -0.0759 -0.1174 -21.29
Долг, млрд $
0.0544 0.0599 0.0611 0.0632 0.0632 0.0597 3.82
Interest income $
0.0000 0.000172 0.000249 0.0019 0.0008 122.71
Расходы на обслуживание долга $
0.0000 0.0014 0.0038 0.005 0.000102 0.000102 0.0026 -48.05
Чист. проц. доходы, млрд $
0.0000 0.000172 0.000249 0.0019 0.0019 0.0008 122.71
Амортизация, млрд $
0.0045 -0.017 0.000172 0.0025 0.0014 0.0012 0.0012 -0.0023 -158.85
Себестоимость, млрд $
0.0000 0.000492 0.0025 0.0014 0.0012 0.0012 0.0014 24.97


Share

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -0.0301 -3.4 -4.64 -3.86 -0.4804 -0.357 -0.357 -2.5475 -36.29
Цена акции ао 22.24 26.54 1.13 1.77 1.73 2.62 2.62 6.76 -37.07
Число акций ао, млн 37.76 17 37 43.95 232.24 250.13 250.13 116.06 71.22
FCF/акцию 0.0036 -2.25 -7.49 -2.58 -0.3461 -0.3262 -0.3262 -2.5985 -32.04


Efficiency

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 825.93 -47.79 -100.68 -352.08 -294.04 -121.94 -121.94 17.60 -183.3060 20.60
ROA, % -7433.33 -46.36 -73.82 -99.69 -74.62 -53.62 -53.62 5.71 -69.6220 2.95
ROIC, % -47.8 -73.28 -95.26 17.65 -60.5400 23.82
ROS, % -6777.82 -722.06 -1071.62 -1071.62 -1071.62 13.36 -2410.7800 -36.94
ROCE, % 3303.7 -17.08 -106.82 -255.51 -78.37 -66.5 -124.71 -124.71 29.73 -126.3820 3.15
Ebit margin, % -6483.45 -689.72 -1070.39 -1070.39 -1070.39 18.53 -2328.4875 -36.26
Рентаб EBITDA, % 0 -6384.05 -680.84 -1055.45 -1055.45 -1055.45 26.10 -2293.9475 -36.23
Чистая рентаб, % 0 -6777.82 -722.06 -1071.62 -1071.62 13.36 -2857.1667 -45.93
Operation Margin, % -6492.69 -468.83 -1097.55 -1097.55 -1097.55 16.64 -2289.1550 -35.88
Доходность FCF, % -10.39 -17.34 -47.15 -29.19 -26.0175 29.47


Coefficients

IFRS
Reporting Annual Quarterly
2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-8.91 -4.56 -1.42 -2.47 69.28 -4.3400 -27.44
P/BV
1.93 3.2 104.67 5.24 6.05 6.05 8.88 24.22 25.67
P/S
39.7 25.4 51.93 51.93 8.07 39.01 9.36
P/FCF
-9.62 -5.77 -2.12 -1.09 -1.54 -1.52 -1.52 8.97 -2.4080 -23.42
E/P
-0.1122 -0.2195 -0.706 -0.4051 -0.9012 -0.7213 -0.7213 0.03 -0.5906 26.86
EV/EBIT
-5.42 -2.11 -0.44 -2.91 -4 -4 -4 88.62 -2.6920 13.65
EV/EBITDA
-3.63 -1.05 -0.4469 -2.94 -4.06 -4.06 53.93 -2.4254 2.26
EV/S
28.53 20.04 42.83 42.83 42.83 8.39 33.56 10.69
EV/FCF
-5.86 -2.63 -0.6302 -3.85 -4.37 -4.37 -4.37 21.66 -3.1700 10.69
Debt/EBITDA
-0.3645 -0.3752 -0.5809 -0.7184 -0.7184 -0.7184 2.61 -0.5515 14.53
Netdebt/Ebitda
4.19 0.4969 0.175 0.7874 0.8625 0.8625 0.8625 0.49 0.6369 11.66
Debt/Ratio
0.2949 0.4746 0.3538 0.394 0.394 0.394 0.24 0.3823 5.97
Debt/Equity
0.6615 63.15 0.8154 0.8833 1.24 1.24 2.82 13.35 13.39
Debt/Net Income
-0.3596 -0.3534 -0.5477 -0.7075 -0.7075 -0.7075 10.75 -0.5351 14.49
PEG
0 0 -67.62
Бета
-3.26 1.11 -1.66 -2.23 3.25 3.25 -0.68 -0.5580 -199.94
Индекс Альтмана
-0.1537 -3.11 -4.32 -0.679 -1.45 -1.45 12.59 -1.9425 56.65


Dividends

IFRS
Reporting Annual
2020 2021 2022 2023 LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 0 0 0 0 1.71
Дивиденды / прибыль, %
0 0 0 155.02


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 LTM CAGR 5
Всего задолженность
0.00015 0.0071 587.99
Персонал, чел
38 38 178 52 8.16
CAPEX/Выручка, %
993.96 47.69 4.49 4.49 -83.47